Please login to the form below
EC
This page shows the latest EC news and features for those working in and with pharma, biotech and healthcare.
Shire’s bleeding disorder drug approved in Europe
The European Commission (EC) has given the green light to Shire’s haemostatic disorder treatment Veyvondi, which is now set to prevent surgical bleeding in adults with von Willebrand disease (VWD).
Latest news
-
MSD wins key EU approval for Keytruda, Alimta combo
The European Commission (EC) based its decision off data from the KEYNOTE-189 trial, which looked at the treatment in patients who were non-, low and high expressions of the
-
Eisai’s Lenvima wins European liver cancer indication
Eisai’ s Lenvima wins European liver cancer indication. EC green-lights the RTK inhibitor as a first-line treatment. ... Japanese pharma group Eisai and partner Merck &Co have received a nod from the European Commission (EC) to market its anti-cancer
-
First migraine prevention drug to hit European market
The European Commission (EC) approved the novel treatment yesterday after it received a positive recommendation from the European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last
-
Alnylam’s amyloidosis drug heads latest crop of CHMP approvals
EC earlier this month.
-
Alnylam’s amyloidosis drug heads latest crop of CHMP approvals
EC earlier this month.
More from news
Approximately 18 fully matching, plus 312 partially matching documents found.
Latest Intelligence
-
Tackling a formidable foe
A year ago the company won EC approval for MAVENCLAD, a course of just 20 tablets that tames the body’s immune response system and can be taken on ten consecutive
-
The sound of silence puts the squeeze on generics and biosimilars
EFPIA issued a statement on its position, stating: “The SPC regime is part of the current EC review of incentives.
-
European CTR implementation advances ethical assessment of clinical trials
well as a clear process of selection of a Central ‘EC’that will be dealing with a trial. ... who would deal with a selection of the appropriate EC, timelines and financial aspects.
-
Europe vs the US: New drug product approvals
pending approval by the European Commission (EC) in January 2017 (compared to no biosimilars gaining EU approval in 2015).
-
Real-world evidence: It’s all in the approach
the EC point out the uses of such data in supporting pharmacovigilance, comparative efficacy and pricing negotiations for new treatments.
More from intelligence
Approximately 0 fully matching, plus 18 partially matching documents found.
Latest appointments
-
CureVac’s CEO appointed to EC High Level Group
CureVac’ s CEO appointed to EC High Level Group. Dr Ingmar Hoerr will advise on Horizon 2020 and future innovation programmes. ... Dr Hoerr joins a panel of 15 group members who will advise the EC on how to strengthen support for breakthrough,
-
New EC health director general takes office
New EC health director general takes office. XavierPrats Monné will report to health commissioner Dr Vytenis Andriukaitis. ... Prats Monné's appointment was part of a reshuffle of the Commission's senior management by president Jean-Claude Juncker and,
-
IMI appoints new chair of scientific committee
IMI appoints new chair of scientific committee. Portugal’ s Maria Beatriz da Silva Lima to join EC’ s collaborative research group. ... the EC and the industry to improve health innovation in Europe.
-
Jonathan Dickinson joins Ariad from BMS
He joins at an important time for Ariad in Europe as it prepares to launch its chronic myeloid leukaemia treatment Iclusig (ponatinib), pending approval from the European Commission (EC).
-
Tonio Borg nominated to replace John Dalli as EC Health Commissioner
Tonio Borg nominated to replace John Dalli as EC Health Commissioner.
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Ensuring quality in medical translation when working ‘blind’
There is also often the need for a review by an Ethics Committee (EC), which can remove some errors, but can introduce spelling or grammar errors too. ... Any EC or client changes should be sent back to the original translators to be checked again.
-
Can rare diseases be a viable option for the pharma industry?
EU has enacted similar legislation, Regulation (EC) No 141/2000, in which pharmaceuticals developed to treat rare diseases are referred to as “ orphan medicinal products”.
-
What we learnt from taking a mobile app through MHRA compliance
Mobile app medical compliance. We launched an app that conforms to the EU Medical Device Directive 2007/47 EC for Rosemont Pharmaceuticals who are now registered as a Class 1 device
-
EC Meetings Company Ltd.
EC Meetings Company Ltd. ECMeetings Malta gives you the opportunity of looking at Malta with a fresh set of eyes, gaining a new perspective on how things could, should and would ... EC Meetings Company Ltd..
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Featured jobs
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
Senior Medical Writer
-
Great salary and benefits
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Events Manager – Med Comms – Surrey
-
Salary TBC
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Account Director
-
Excellent benefits
-
Senior Medical Writer
-
Competitive Salary
-
Associate Medical Director
-
Highly Competitive
-
Account Director
-
£48, 000 - £60, 000
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
-
New Business Director - PR
-
Competitive Salary and benefits
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
- Director, Market Access / HEOR - North-West
-
Negotiable
- Account Manager / Senior Account Manager
-
35, 000-40, 000
Subscribe to our email news alerts
- Oral Appliances lead Sleep Apnea Devices Market Growth, Shows Recent Analysis
- Animal Healthcare Market is poised to cross USD 36 billion by 2024
- Fishawack launches new website and introduces new structure for growth
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- Orphan drugs from Biogen and Amicus win UK Prix Galien
- AZ’s MYSTIC survival data is in – and it’s a bust
PMHub
Cogora
Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
